A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
ESTRADIOL, SENSITIVE
Test CodeLAB8033
CPT Codes
82670
Preferred Specimen
1 Gold tube (SST)

Patient Preparation
None
Minimum Volume
0.5 mL
Other Acceptable Specimens
1 Lavender tube (EDTA)

OR
1 Green tube (Lithium Heparin)

OR

OR
1 Green tube (Lithium Heparin)
OR
Instructions
Centrifuge for complete separation of serum or plasma from red cells. Aliquot plasma into a transfer tube.
Transport Container
Gold tube or Transfer tube
Transport Temperature
Refrigerate
Specimen Stability
- 15-30°C up to 8 hours
- 2-8°C up to 7 days
- Frozen samples are stable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolyzed samples will be rejected
Methodology
Chemiluminescent Immunoassay
Setup Schedule
M, T, W, Th, F, Sa, Su
As received
As received
Report Available
Same day tested
Limitations
The Access Sensitive Estradiol assay results are not intended to be used to measure the effectiveness of exogeneous estradiol supplementation. Test results may be either falsely increased or falsely decreased if they are measured after a patient receives estradiol supplements. Consider the patient’s total clinical presentation when interpreting results.
Reference Range
Non-Pregnant Females | pg/mL |
---|---|
Early-follicular | 22.4 - 115 |
Mid-follicular | 25.0 - 115 |
Ovulatory Peak | 32.1 - 517 |
Mid-Luteal | 36.5 - 246 |
Post-Menopausal Females | pg/mL |
Not on hormone therapy | 0 - 25.1 |
Adult Males | pg/mL |
0 - 31.5 |
Pediatric | ||
Sex | Age | pg/mL |
Male or Female | 0 - <1 year | 0 - 38.2 |
Female, pre-puberty | 1 - <12 years | 0 - 16.0 |
Female, puberty | 12 - <19 years | 0 - 196 |
Male, pre-puberty | 1 - <12 years | <15 |
Male, puberty | 12 - <19 years | 0 - 34.8 |
Clinical Significance
Monitors the level of biologically most active estrogen.